Cargando…

Targeted therapy for renal cell carcinoma: The next lap

Advances in rationally targeted therapeutics over the last decade have transformed the clinical care of advanced kidney cancer. While oncologists consolidate the gains of the wave of new agents, comprising a panoply of anti-vascular endothelial growth factor multi-targeted tyrosine kinase inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanesvaran, Ravindran, Tan, Min-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986548/
https://www.ncbi.nlm.nih.gov/pubmed/24737951
http://dx.doi.org/10.4103/1477-3163.127638

Ejemplares similares